Completed
Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer
NCT00072176
- Conditions
- Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, +19 more
- Locations
-
- National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada